Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
19.17
+0.31 (1.67%)
At close: Jun 24, 2025, 4:00 PM
19.16
0.00 (-0.03%)
After-hours: Jun 24, 2025, 4:04 PM EDT
Castle Biosciences Stock Forecast
Stock Price Forecast
The 6 analysts that cover Castle Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $37.67, which forecasts a 96.56% increase in the stock price over the next year. The lowest target is $35 and the highest is $41.
Price Target: $37.67 (+96.56%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 21, 2025.
Analyst Ratings
The average analyst rating for Castle Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $44 → $40 | Buy | Maintains | $44 → $40 | +108.71% | May 21, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $40 → $35 | Strong Buy | Maintains | $40 → $35 | +82.62% | May 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $42 → $37 | Strong Buy | Maintains | $42 → $37 | +93.06% | May 6, 2025 |
| Baird | Baird | Buy Maintains $36 → $37 | Buy | Maintains | $36 → $37 | +93.06% | Feb 28, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $41 | Buy | Reiterates | $41 | +113.93% | Jan 2, 2025 |
Financial Forecast
Revenue This Year
299.98M
from 332.07M
Decreased by -9.66%
Revenue Next Year
304.05M
from 299.98M
Increased by 1.36%
EPS This Year
-2.43
from 0.62
EPS Next Year
-1.75
from -2.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 311.6M | 325.7M | 352.1M | ||
| Avg | 300.0M | 304.1M | 329.9M | ||
| Low | 285.9M | 277.1M | 303.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -6.2% | 8.6% | 15.8% | ||
| Avg | -9.7% | 1.4% | 8.5% | ||
| Low | -13.9% | -7.6% | -0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.80 | -1.04 | -1.47 | ||
| Avg | -2.43 | -1.75 | -1.74 | ||
| Low | -2.67 | -2.41 | -1.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.